ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma

OBJECTIVE: ARID1A has been discovered as a potential cancer biomarker. But its role in hepatocellular carcinoma (HCC) is subject to considerable dispute. METHODS: The relationship between ARID1A and clinical factors was investigated. Clinicopathological variables related to overall survival in HCC s...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yuanyuan, Tang, Xinfang, Li, Changcheng, Su, Ying, Wang, Xiaoyu, Li, Ning, Zhang, Anna, Jiang, Feng, Wu, Chuyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752298/
https://www.ncbi.nlm.nih.gov/pubmed/35028302
http://dx.doi.org/10.1155/2022/3163955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752298/
https://www.ncbi.nlm.nih.gov/pubmed/35028302
http://dx.doi.org/10.1155/2022/3163955

Ejemplares similares